University of PittsburghUniversity of Pittsburgh
Startups
TechnologiesStartupsExpress LicensesCollectionsChat with AI
Sign in
University of Pittsburgh

MDR Therapeutics

OverviewRequest InfoMore Like ThisExpress Licenses

Sector

Therapeutics

Therapeutic Areas

RespiratoryImmunology

Therapeutic Indications

Pneumonia

Funding Stage

Seed

Website

https://www.mdrtherapeutics.com

MDR Therapeutics is developing a platform-based vaccine technology against bacterial pneumonia. The vaccines use components of bacterial outer membranes rather than polysaccharide capsules, and are designed to trigger mucosal T-cell and B-cell responses that give serotype-independent protection. [1]

The company is also working on needleless delivery so that its vaccines can be administered worldwide. Its targets include Streptococcus pneumoniae and gram-negative bacteria of the Enterobacteriaceae family. [1]

Discover More with AI